The accumulation of protein-bound toxins in dialyzed patients is strongly associated with their high morbidity and mortality. The bioartificial kidney device (BAK), containing proximal tubule epithelial cells (PTEC) seeded on functionalized synthetic hollow fiber membranes (HFM), may be a powerful solution for the active removal of those metabolites. In an earlier study, we developed an upscaled BAK containing conditionally immortalized human PTEC (ciPTEC) with functional organic cationic transporter 2 (OCT2). Here, we first extended this development to a BAK device having cells with the organic anionic transporter 1 (OAT1), capable of removing anionic uremic wastes. We confirmed the quality of the ciPTEC monolayer by confocal microscopy and paracellular inulin-FITC leakage, as well as, by the active transport of anionic toxin, indoxyl sulfate (IS). Furthermore, we assessed the immune-safety of our system by measuring the production of relevant cytokines by the cells after lipopolysaccharide (LPS) stimulation. Upon LPS treatment, we observed a polarized secretion of pro-inflammatory cytokines by the cells: 10-fold higher in the extraluminal space, corresponding to the urine compartment, as compared to the intraluminal space, corresponding to the blood compartment. To the best of our knowledge, our work is the first to show this favorable cell polarization in a BAK upscaled device.
Introduction
Despite the ongoing progress in dialysis therapy, only small and middle-size xenobiotics can be eliminated. The removal of bigger size solutes and protein-bound toxins is limited (Krieter et al., 2009; Meyer et al., 2005) . Recently, the accumulation of these protein-bound solutes has been strongly associated with the fatal outcome of the patients (Meijers et al., 2010; R. Vanholder, Schepers, Pletinck, Nagler, & Glorieux, 2014) . Therefore, there is a strong need for novel strategies and concepts for their removal (R. C. Vanholder, Eloot, & Glorieux, 2015) , such as a bioartificial kidney (BAK). The BAK aims at mimicking the functional kidney by making use of proximal tubule epithelial cells (PTEC), equipped with a broad range of transporters, which normally mediate the excretion of those solutes . This device consists of living membranes comprising of tight monolayer of renal cells with preserved functional organic ion transporters, grown on an artificial porous hollow fiber membrane (HFM).
In recent years, several studies have presented BAK prototypes making use of human PTEC (Humes et al., 2002; Oo et al., 2011; Oo, Kandasamy, Tasnim, & Zink, 2013; Saito et al., 2012; Sanechika et al., 2011; Sun et al., 2011; Takahashi et al., 2013; Tumlin et al., 2008) , showing a preserved phenotype and sometimes metabolic and/or endocrine functions in vitro or in vivo. However, mostly primary cell lines were used which are characterized by limited availability, donor to donor variation and the loss of phenotype or functionality upon culturing. The recently developed and well-characterized human conditionally immortalized PTEC (ciPTEC) line appears to be a suitable candidate for an efficient BAK system (Chevtchik et al., 2016; Jansen et al., 2015; Jansen et al., 2016; Jansen et al., 2014; Nieskens et al., 2016; Schophuizen et al., 2015; Wilmer et al., 2010) . These cells are transduced with human telomerase (hTERT) that limits replicative senescence by telomere length maintenance. In addition, their proliferation is controlled by the temperature sensitive mutant of SV40 Large T antigen (SV40tsA58), allowing proliferation at 33 °C and differentiation in mature PTEC at 37 °C. Due to these modifications the cell line has high availability, limited senescence, and can be used up to a high passage number.
A recent study on small single HFM showed an active excretion of indoxyl sulfate (IS) and kynurenic acid (KA) by ciPTEC (Jansen et al., 2016) through the concerted action of organic anion transporter-1 (OAT1), breast cancer resistance protein (BCRP) and multidrug resistance protein-4 (MRP4). This property of the ciPTEC is of high importance for BAK application, considering that most of the protein-bound toxins are anionic molecules (Miyamoto et al., 2011; R. Vanholder, De Smet, Glorieux, Argiles, et al., 2003) . In the present work, we first developed an upscaled living membrane to support the OAT1-expressing ciPTEC line. The transport properties and the quality and function of the grown ciPTEC monolayer were investigated, including the expression of zonula occludens-1 (ZO-1) protein and the diffusion of fluorescein isothiocyanate (FITC)-labelled-inulin (inulin-FITC).
Furthermore, we studied the transport of an anionic uremic toxin, IS, mediated by the combined action of OAT1, BRCP and MRP4, in the absence or in the presence of the OAT1 inhibitor, probenecid.
A very important issue related to the clinical implementation of the BAK device is its safety. It is crucial to investigate whether the device with the human allogenic cells induces immune and inflammatory responses in the host. Besides, the high uremic toxins concentrations in kidney patients are often associated with inflammation, which may as well be detrimental for the BAK (Hsu et al., 2014) . A first assessment of the immunogenicity of the ciPTEC lines using flat membranes with a small surface area (1.12 cm 2 ) showed that ciPTEC have low immunogenicity in vitro, although able to secrete several pro-inflammatory cytokines that could potentially mediate a non-specific inflammatory response (Mihajlovic et al., 2017) . In this work, we investigated whether there is polarization of the production of pro-inflammatory and immune mediators by the ciPTEC cultured in the BAK system. We measured the release of the most relevant pro-inflammatory mediators -IL-6, IL-8 and TNF-α -and sHLA-class I without or with exposure to lipopolysaccharide (LPS) or interferon-γ (IFN-γ) in both -dialysate and blood -compartments of the system. To the best of our knowledge, our work is the first to focus on this important issue for the development of BAK devices.
Materials and Methods

Chemicals
All chemicals were purchased from Sigma-Aldrich (Zwijndrecht, The Netherlands) unless stated otherwise. MicroPES TF10 hollow fiber capillary membranes (HFM) (wall thickness 100 µm, inner diameter 300 µm, max pore size 0.5 µm) were purchased from 3M -Membrana GmbH (Wuppertal, Germany).
Module preparation, HFM sterilization, coating and characterization
The modules were prepared following the protocol presented previously (Chevtchik et al., 2016) . A dual coating of L-Dopa and Collagen IV coating was applied to the fibers, at 37 °C on a shaking device, for a duration of 20 h and 2 h respectively (Chevtchik et al., 2016) . The HFM transport properties (water permeability) was measured before and after sterilization and before and after 
2.3.
Cell culture and modules handling
The ciPTEC OAT-1 expressing, urine-derived, cell line (Nieskens et al., 2016; Wilmer et al., 2010 ) was cultured at 33°C proliferating temperature and at 37°C maturation temperature in ciPTEC complete medium. The latter was prepared as described previously (Chevtchik et al., 2016) with the difference that ciPTEC were always cultured in absence of antibiotics up to a maximum of 60 passages. The modules' handling and cell seeding was performed as reported previously (Chevtchik et al., 2016) . Briefly, prior to cell seeding, modules were incubated for 1 h in ciPTEC complete medium. Proliferating 90% confluent ciPTEC were detached using Accutase (StemPro® Accutase®, Life Technologies Europe BV, Bleiswijk, the Netherlands), centrifuged and suspended at a concentration of 2.0-2.5 million cells/ml in the ciPTEC complete medium. The modules'
extraluminal space was completely filled with the cell suspension. To promote initial cell attachment, the modules were placed at 33°C, 5% CO2 for 8 h, with a rotation of 90 degrees every 2 h. Afterwards, the modules were washed with the ciPTEC complete medium, provided with gas exchange filters and the cell proliferation was allowed for additional 64h. Finally, the temperature was changed to 37°C for 7 days to allow ciPTEC maturation. During the culture period, ciPTEC were supplemented with fresh culture medium every second day. 
Immunochemistry
Transepithelial barrier function
Paracellular permeability of the mature living membranes was quantified following the previously described method (Chevtchik et al., 2016) . After washing the modules with Krebs-Henseleit buffer supplemented with HEPES (10 mM; KHH buffer), inulin-FITC (0.1 mg/ml in KHH buffer) was perfused at 18 ml/h at 37°C for 15 min. The inulin-FITC leakage was determined prior to perform functional IS transport. In some of the modules, the inulin-FITC leakage was determined before and after the IS transport experiment and after LPS or IFN-γ exposure to assess the integrity of the monolayer after the functional tests.
Functional organic anion transport
Transepithelial transport of indoxyl sulfate (IS) through the HFM with matured ciPTEC was studied using a similar perfusion set-up as was used for the barrier function assay. First, fibers were preincubated in KHH buffer without or with probenecid (p) at concentrations 100 µM (p100) or 500 µM (p500) at 37°C for 15 min. Next, the fibers were perfused using 100 µM IS in KHH buffer in the presence or absence of inhibitors for 10 min at a flow rate of 18 ml/h. Samples from both permeate and outlet were collected. IS concentrations were measured with a Jasco HPLC system equipped with a pump (PU-2080) an autosampler (PF-2020), UV/VIS detector (UV-2070), fluorescence detector (FP-2020). The protocol was adapted from (Pavlenko et al., 2016) . The excitation and emission wavelength for the fluorescence detector were set at 272 nm and 374 nm, respectively.
The eluents used were ammonium formate (MW 63.06 g/mol) buffer 50mM + 10% Methanol at pH = 3.0. the flow rate was set at 0.5 ml/min.
Production of the pro-inflammatory cytokines and human leukocyte antigens
The apical and basolateral sides of the living membrane were exposed to the following treatments depending on the experimental set-up: interferon-γ (IFN-γ) 300 ng/ml, lipopolysaccharide (LPS) 10 μg/ml. The production of IL-6, IL-8, TNF-α and soluble HLA-class I (sHLA-class I) molecules in various stimulatory conditions, was measured by means of enzyme-linked immuno-sorbent assays (ELISAs).
Cell culture supernatants were collected from apical (external, volume ~3 ml) and basolateral (internal, volume ~0.4 ml) compartments after exposure to various stimulatory conditions, centrifuged for 10 min at 240·g, 4°C, and stored at -80°C. DuoSet® ELISA Development Systems kits (IL-6 #DY206, TNF-α #DY210, IL-8 #DY208; R&D systems, Abingdon, UK) and Human MHC class-I kit (Proteintech, Chicago, IL, USA) were used to quantify the cytokine and sHLA-class I levels respectively, in cell culture supernatants according to manufacturer's instructions. The optical density was determined immediately using the iMark Microplate Absorbance Reader (Bio-Rad, Japan) set to 450 nm. Each sample was measured in duplicates and quantification was done using Microplate Manager Software (version 6.0, Bio-Rad Laboratories, Hercules, CA, USA) capable of generating a four-parameter logistic (4-PL) curve-fit.
Data analysis
Every experiment was performed at least in duplicate. The number of samples (n) measured is indicated in each figure legend. The results are presented as mean ± standard deviation or standard error of the mean. Statistical analysis of the cell monolayer integrity and function was performed in the SPSS software (IBPM SPSS Statistics version 23.0) using a one-way analysis of variance (ANOVA) or Student's t-test, where appropriate. Statistical analysis of the production of proinflammatory cytokines was performed in the GraphPad Prism software (GraphPad software, version 5.03; La Jolla, CA, USA), using either unpaired two-tailed test (for differences between two compartments in the same module) or one way ANOVA followed by Tukey's multiple comparison test (for differences between treatments and different modules). A P-value of < 0.05 was considered significantly different.
Results
HFM characterization
The staining (Figure 2A) shows that the cells have proper shape, structure and morphology, additionally confirming the epithelial character of the cell monolayer.
Cell monolayer integrity and function
Inulin transport through the mature cell monolayer occurs in a non-active manner, via diffusion through the inter-cellular junctions. Therefore, the inulin-FITC leakage test is representative of the monolayer tightness (Schophuizen et al., 2015) . For a tight cell monolayer, inulin-FITC leakage is expected to be a lot lower than through HFM without cells. Figure 2C presents the inulin-FITC leakage through the tested HFM, for which the fibers without cells is set to 100 %. The leakage of the HFM with a ciPTEC monolayer is as low as 32 ± 11 %. The data presented here arise from 4 experiments and 32 different modules.
Figure 2. Monolayer quality of ciPTEC cultured on HFM. (A, B) Representative confocal microscopy images of ciPTEC cultured on HFM with the DAPI staining of nuclei (blue), the cytoskeleton (green) and the immunostaining for ZO-1 (red). (C) Inulin-FITC paracellular leakage, ratio HFM with cells /HFM without cells.
The data presented here arose from 4 experiments and 32 different modules. Data are presented as mean ± standard deviation. * P < 0.001 using a one-way ANOVA.
We next assessed the activity of the transporter responsible for anionic urinary uremic toxin excretion, viz. OAT1, by perfusing the living membranes with IS in the absence or presence of the OAT1 inhibitor, probenecid. Figure 3A shows the scheme of the experimental set-up and Figure 3B shows the transport results where the IS transport alone through the cell monolayer was set at 100 %. The IS transport is inhibited by ~50 % by both concentrations of probenecid (IS transport becomes 48 ± 20 % and 50 ± 15 % of the original intensity, for p100 and p500 respectively), suggesting maintained cell function. The inhibition of IS transport was comparable for both concentrations of probenecid, suggesting that the saturation of the transporters was reached. After the inhibition tests, the cell monolayer was still intact as suggested by the low inulin-FITC leakage of around 30 % (see Figure 2C ). The absolute values of the IS clearance are presented in the supplementary figure S4. (Jansen et al., 2016 
Figure 3. Functional OAT1-mediated IS transport. (A) Schematic presentation of the experimental set up of IS transepithelial transport in the absence (I) or presence (II) of probenecid. Adapted from
Production of the inflammatory and immune mediators
To assess whether the living membrane mediates an inflammatory or immune response, we evaluated the release of IL-6, IL-8, TNF-α and sHLA-class I in both the extraluminal (apical) and in the intraluminal (basolateral) compartments. Figure 4A shows a schematic representation of the experimental set-up in the case of exposure to LPS; an identical setup was used for the exposure to IFN-γ and the release of sHLA-class I. Figure 4B -E show the release of pro-inflammatory cytokines IL-6, IL-8 and TNF-α and the sHLA-class I.
Prior to exposure to LPS, the concentrations of IL-6 and IL-8 were found to be 2 to 3 times higher in the extraluminal compartment ((27 ± 4)· 10 3 pg/ml and (10 ± 1) · 10 3 pg/ml respectively) than in the intraluminal compartment ((9 ± 4) · 10 3 pg/ml and (4 ± 1) · 10 3 pg/ml respectively). When the ciPTEC were directly exposed to LPS, the concentration of IL-6 and IL-8 increased in the extraluminal compartment (more than 10 times -(496 ± 267) · 10 3 pg/ml and (103 ± 9) · 10 3 pg/ml respectively).
When LPS was administrated intraluminally, the extraluminal concentration of IL-6 and IL-8 increased slightly less (more than 5 times -(100 ± 15) · 10 3 pg/ml and (67 ± 7) · 10 3 pg/ml, respectively), most likely due to the small mass transfer resistance of the HFM. On the other hand, the intraluminal concentration of IL-6 remained the same for both extraluminal and intraluminal exposures to LPS ((19 ± 4) · 10 3 pg/ml and (16 ± 2) · 10 3 pg/ml, respectively). In similar conditions, the intraluminal concentration of IL-8 slightly increased: 2 times after extraluminal exposure and 3 times after intraluminal exposure ((9 ± 2) ·10 3 pg/ml and (13 ± 2) · 10 3 pg/ml, respectively).
The concentrations of TNF-α did not vary in all cases and remained very low (100-300 pg/mL), in agreement with our previous findings (Mihajlovic et al., 2017; Peters et al., 2015) . If we, however, estimate the absolute amount of TNF-α in both compartments (based on the volume of each compartment, we observe that the amount of TNF-α is higher in the extraluminal than in the intraluminal compartment ( Figure S3 ).
Similarly to TNF-α, the absolute levels of sHLA-class I were rather low (concentrations < 20 pg/ml) compared to normal serum levels (Rhynes et al., 1993; Zavazava, Leimenstoll, & Müller-Ruchholtz, 1990 ). Hence, in agreement with IL-6 and IL-8, the concentrations of sHLA-class I were 2 to 3 times higher in the apical than in the basolateral compartment (15 ± 6 pg/ml and 5 ± 1 pg/ml respectively).
The apical concentration of sHLA-class I did not significantly change after the apical and basolateral exposures to IFN-γ (20 ± 5 pg/ml and 19 ± 4 pg/ml respectively), although a slight (2-fold) increase was observed in the basolateral compartment after basolateral exposure (9 ± 2 pg/ml).
Overall, for all of the configurations tested, the concentration of IL-6, IL-8 and sHLA-class I was higher in the extraluminal compartment, corresponding to dialysate, compared to the intraluminal one, which would correspond to patient's blood. This conclusion holds true also for the absolute amounts of pro-inflammatory cytokines and sHLA-class I in both compartments (see supplementary figure S3 ). Finally, to assess the integrity of the cell monolayer during these tests, additional Inulin-FITC leakage tests were performed on the HFM after exposure to stimulatory conditions (LPS and IFN-γ), which was found to be rather low, 27.4 ± 14.9 % ( Figure 3C ), and similar to that before the stimulatory experiments. 
(B, C, D, E) Effect of 24 h basolateral or apical exposure to LPS (10 μg/ml) (B, C, D) or IFN-γ (300 ng/ml) (E) on production of pro-inflammatory cytokines (IL
Discussion
In this study, we developed upscaled (4 cm 2 ) 3D modules containing double coated MicroPES HFM supporting OAT1-expressing ciPTEC. With this system, we investigated the secretion of the proinflammatory cytokines IL-6 and IL-8 and sHLA-class by the cells in response to LPS or IFN-γ, both basolaterally and apically, to mimic inflammatory conditions.
Confocal microscopic analysis of the ciPTEC monolayer after 7 days of maturation at 37°C demonstrated regular nuclei, homogeneous cell structure and morphology, and abundant expression of the tight junction protein ZO-1. This underlines the epithelial character of the ciPTEC monolayer, which was confirmed further by limited inulin-FITC diffusion in agreement to earlier studies. Indeed, the earlier reported values -30 ± 10 % for an upscaled system (Chevtchik et al., 2016 ) and 31 ± 9 % (Jansen et al., 2015) for a small scale system -are identical to the Inulin-FITC leakage percentage -32 ± 11 % -reported here. In addition, the paracellular inulin-FITC leakage remained low after exposure to IS, LPS or IFN-γ, confirming the preservation of intact ciPTEC monolayers after the exposure to toxins and to inflammatory stimuli.
Our system demonstrated the active transport of IS, an anionic uremic toxin from the family of the protein bound toxins (R. Vanholder, De Smet, Glorieux, Argiles, et al., 2003) , reported as strongly linked to the fatal outcome in kidney patients (R. Vanholder, De Smet, Glorieux, & Dhondt, 2003; R. Vanholder et al., 2014) . This active transport indicates the presence of functional OAT1-mediated transport. OAT1 is expressed at the basolateral membrane of PTEC, responsible for the uptake of anionic uremic metabolites (Jansen et al., 2016; Nieskens et al., 2016) and is crucial for their renal elimination. BCRP and MRP4 transporters, located on the apical membrane of PTEC, are responsible for the toxin excretion to the urine in the matured ciPTEC monolayer (Jansen et al., 2016) . When the modules were incubated with probenecid, an inhibitor of OAT1, the transport of IS was reduced by approximatively 40%. In comparison to the study performed on a short single HFM (Jansen et al., 2016) , we also found a similar inhibition of the transport of IS (100 μM) by probenecid 100 μM:
48 ± 31 % (Jansen et al., 2016) in the single small HFM versus 55 ± 6 % now in the upscaled system, P < 0.001.
Finally, we studied the production of IL-6, IL-8, TNF-α and sHLA-class I, in basic conditions and in response to LPS and IFN-γ, which we used to mimic inflammatory conditions as observed in uremic syndrome. For the BAK, the production of pro-inflammatory cytokines is important for the activation of immune cells and propagation of inflammatory response usually present in CKD patients, which could have undesirable effects. In most studies on BAK reported in the literature (Humes et al., 2002; Oo et al., 2011; Oo et al., 2013; Saito et al., 2012) , the concentrations of cytokines were measured only from the waste (apical) compartment in vitro or the blood (basolateral) compartment in vivo. In our work, we measured the concentrations of proinflammatory cytokines in both apical and basolateral compartments and we found that they were very low and their absolute values between extraluminal and basolateral compartment were significantly different. Both in the absence and in the presence of LPS or IFN-γ, the secretion of IL-6, IL-8 and of sHLA-class I was significantly higher to the apical side -corresponding to dialysate compartment -compared to the basolateral secretion -corresponding to blood side.
Overall, our results indicate that the here described BAK device consists of functional polarized ciPTECs, which secrete higher amounts of cytokines and sHLA-class-I molecules towards the dialysate compartment, thereby greatly reducing the risks associated with eventual proinflammatory and immunogenic effects of the cells.
Conclusion & outlook
This work presented the successful upscaling of the living membranes containing functional OAT1-mediated transport crucial for the removal of uremic anionic toxins, such as IS. Importantly, the ciPTEC were fully polarized since the release of pro-inflammatory cytokines IL-6 and IL-8 and of sHLA-class I was mainly oriented towards the apical side, or dialysate compartment, and not towards the basolateral side -corresponding to the side of the patient's body fluid.
The next step towards the development of a functional BAK device is to culture the cells while exposing them to a unidirectional flow with relative shear stress to mimic the natural kidney proximal tubule physiology. There is evidence that cell metabolism is stimulated when cells are cultured under dynamic conditions (Jang et al., 2013; Kim, Putnam, Kulik, & Mooney, 1998; Li & Cui, 2014; Sánchez-Romero, Meade, & Giménez, 2016; Weinbaum, Duan, Satlin, Wang, & Weinstein, 2010) , which might further stimulate toxin removal. Moreover, a ciPTEC-based BAK device should ensure a sufficient toxin clearance for prolonged sessions. Here, the function of the living membrane was tested for 10 min. Future work should evaluate longer clearance periods, using plasma or blood samples from CKD patients. For the ciPTEC, the combination on L-Dopa and collagen IV worked best in the time scale of our experiments. If necessary, we would investigate in the future the application of renal ECM (eg. from decellularised kidneys) to the fibers, too. 
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